| Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection J Dyall, CM Coleman, T Venkataraman, MR Holbrook, J Kindrachuk, ... Antimicrobial agents and chemotherapy 58 (8), 4885-4893, 2014 | 729 | 2014 |
| Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection KA Kulcsar, CM Coleman, SE Beck, MB Frieman JCI insight 4 (20), 2019 | 393 | 2019 |
| Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice CM Coleman, YV Liu, H Mu, JK Taylor, M Massare, DC Flyer, GM Glenn, ... Vaccine 32 (26), 3169-3174, 2014 | 330 | 2014 |
| HIV interactions with monocytes and dendritic cells: viral latency and reservoirs CM Coleman, L Wu Retrovirology 6 (1), 1-12, 2009 | 316 | 2009 |
| Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus fusion CM Coleman, JM Sisk, RM Mingo, EA Nelson, JM White, MB Frieman Journal of virology 90 (19), 8924-8933, 2016 | 289 | 2016 |
| Abelson kinase inhibitors are potent inhibitors of severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus fusion CM Coleman, JM Sisk, RM Mingo, EA Nelson, JM White, MB Frieman Journal of virology 90 (19), 8924-8933, 2016 | 289 | 2016 |
| Coronaviruses: important emerging human pathogens CM Coleman, MB Frieman Journal of virology 88 (10), 5209-5212, 2014 | 252 | 2014 |
| Pre-and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection KE Pascal, CM Coleman, AO Mujica, V Kamat, A Badithe, J Fairhurst, ... Proceedings of the National Academy of Sciences 112 (28), 8738-8743, 2015 | 244 | 2015 |
| Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo S Weston, CM Coleman, R Haupt, J Logue, K Matthews, Y Li, HM Reyes, ... Journal of virology 94 (21), e01218-20, 2020 | 222 | 2020 |
| Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2 In Vitro and SARS-CoV In Vivo S Weston, CM Coleman, R Haupt, J Logue, K Matthews, Y Li, HM Reyes, ... Journal of virology 94 (21), e01218-20, 2020 | 222 | 2020 |
| SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interferons C St Gelais, S de Silva, SM Amie, CM Coleman, H Hoy, JA Hollenbaugh, ... Retrovirology 9 (1), 1-15, 2012 | 216 | 2012 |
| SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interferons C St Gelais, S de Silva, SM Amie, CM Coleman, H Hoy, JA Hollenbaugh, ... Retrovirology 9 (1), 1-15, 2012 | 216 | 2012 |
| Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus CM Coleman, KL Matthews, L Goicochea, MB Frieman The Journal of general virology 95 (Pt 2), 408, 2014 | 144 | 2014 |
| Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo T Luke, H Wu, J Zhao, R Channappanavar, CM Coleman, JA Jiao, ... Science translational medicine 8 (326), 326ra21-326ra21, 2016 | 120 | 2016 |
| Overactive epidermal growth factor receptor signaling leads to increased fibrosis after severe acute respiratory syndrome coronavirus infection T Venkataraman, CM Coleman, MB Frieman Journal of virology 91 (12), e00182-17, 2017 | 116 | 2017 |
| Overactive epidermal growth factor receptor signaling leads to increased fibrosis after severe acute respiratory syndrome coronavirus infection T Venkataraman, CM Coleman, MB Frieman Journal of virology 91 (12), e00182-17, 2017 | 116 | 2017 |
| The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling KL Matthews, CM Coleman, Y van der Meer, EJ Snijder, MB Frieman The Journal of general virology 95 (Pt 4), 874, 2014 | 115 | 2014 |
| Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses AO Adedeji, K Singh, A Kassim, CM Coleman, R Elliott, SR Weiss, ... Antimicrobial agents and chemotherapy 58 (8), 4894-4898, 2014 | 109 | 2014 |
| MERS-CoV spike nanoparticles protect mice from MERS-CoV infection CM Coleman, T Venkataraman, YV Liu, GM Glenn, GE Smith, DC Flyer, ... Vaccine 35 (12), 1586-1589, 2017 | 94 | 2017 |
| One-health: a safe, efficient, dual-use vaccine for humans and animals against Middle East respiratory syndrome coronavirus and rabies virus C Wirblich, CM Coleman, D Kurup, TS Abraham, JG Bernbaum, ... Journal of virology 91 (2), e02040-16, 2017 | 88 | 2017 |
